✨
AI Summary
- Earli uses bioAI, synthetic DNA, and nanoparticles to reprogram cancer cells into immune therapy factories.
- Discusses China's biotech five-year plan and U.S. funding cycles pushing innovation offshore.
- Proposes a U.S. sovereign wealth fund to support early-stage drug development and retain innovation.
Guests on This Episode
More from Life Science Connect
